Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo Buys Okairos for $324 Million to Grow in Vaccines
Bloomberg
Wednesday, May 29, 2013 - 8:23am
tags:
GSK, vaccines, Okairos, M&A
Amgen to make move into Japan, takes on Astellas as partner
Yahoo/Reuters
Wednesday, May 29, 2013 - 8:21am
tags:
Japan, Amgen, Astellas
Arena Surges On Pre-Launch
Seeking Alpha
Wednesday, May 29, 2013 - 8:21am
tags:
drug launches, Belviq, Arena Pharmaceuticals, obesity
U.S. Company Credit Swaps Hold; Pfizer Sells $4 Billion in Bonds
Bloomberg
Wednesday, May 29, 2013 - 8:19am
tags:
Pfizer, bonds
Making The Call: Pharmacyclics FDA Drug Approval Before Year End
TheStreet.com
Wednesday, May 29, 2013 - 8:18am
tags:
FDA, Pharmacyclics, JNJ, ibrutinib, B-cell cancers
As Forest CEO Plans Retirement, The Feds Issue A New Subpoena
Pharmalot
Tuesday, May 28, 2013 - 6:31pm
tags:
Tudorza Pressair, Howard Solomon, Forest Labs, DOJ
3 Stocks to Watch Ahead of ASCO
Motley Fool
Tuesday, May 28, 2013 - 6:28pm
tags:
cancer, ASCO, nivolumab, Bristol-Myers Squibb, idelalisad, Gilead, PEGPH20, Halozyme, pancreatic cancer
Kentucky attorney general sues Johnson & Johnson over Risperdal marketing
Yahoo/Fly on the Wall
Tuesday, May 28, 2013 - 6:17pm
tags:
Kentucky, Risperdal, JNJ
Amarin slumps as AstraZeneca buys potential rival
Yahoo/AP
Tuesday, May 28, 2013 - 6:16pm
tags:
Amarin, AstraZeneca, M&A, Omthera
Analysts: Merck May Benefit From Restructuring and 3 More Research Notes to Browse
Wall St. Cheat Sheet
Tuesday, May 28, 2013 - 6:14pm
tags:
Merck, restructuring
5 Drugs Stocks Driving The Industry Higher
TheStreet.com
Tuesday, May 28, 2013 - 6:13pm
tags:
Biogen Idec, Amgen, Valeant Pharmaceuticals, Celgene, Abbott Laboratories, AstraZeneca
Valeant, Bausch & Lomb And The Long Reach Of Fred Hassan
Pharmalot
Tuesday, May 28, 2013 - 10:56am
tags:
Valeant Pharmaceuticals, Bausch & Lomb, Fred Hassan
Prosensa IPO Filing Looks Good For Sarepta Therapeutics
TheStreet.com
Tuesday, May 28, 2013 - 10:54am
tags:
IPOs, Prosensa, Sarepta Therapeutics, GSK
Siga Rises on Chance to Reargue PharmAthene Damages
Bloomberg
Tuesday, May 28, 2013 - 10:53am
tags:
PharmAthene, SIGA technologies, ST-246
Clearing The Air On The Sanofi-Regeneron Asthma Drug Trial
Seeking Alpha
Tuesday, May 28, 2013 - 9:30am
tags:
asthma, Sanofi, Regeneron, dupilumab
Chronic disease conditions could attract pharma-accountable care organization collaboration
FT.com
Tuesday, May 28, 2013 - 8:58am
tags:
chronic disease, ACOs
Omthera shares up 89% after AstraZeneca deal
Marketwatch
Tuesday, May 28, 2013 - 8:36am
tags:
Omthera, M&A, AstraZeneca
Valeant: FDA Rejects Nail Fungus Treatment Efinaconazole Over Container
FOX Business
Tuesday, May 28, 2013 - 8:35am
tags:
FDA, Valeant Pharmaceuticals, nail fungus, efinaconazole
J&J's DePuy can't dodge $8.3M metal hip implant verdict
Mass Device
Tuesday, May 28, 2013 - 8:32am
tags:
JNJ, DePuy, hip implants, settlements, devices
Oasmia Rises on New Cancer Combination Drug
Bloomberg
Tuesday, May 28, 2013 - 8:31am
tags:
Oasmia, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.